2Chikusa Y, Fujimoto T,Ikunaka M, et al. (S)-3-Methyl-2-phenylbutylamine, a versatile agent to resolve chiral, racemic carboxylic acids[J]. Org Proc Res Dev, 2002,6(3) :291 - 296.
3Yamaguchi T, Yanagi T,Hokari H, et al. Preparation of optically active succinic acid derivatives.Ⅰ.optical resolution of 2-benzyl-3-(cis-hexahydroisoindolin-2-yl-carbonyl )-propionic acid [J].Chem Pharm Bull,1997,45(9):1518-1520.
4Toshiaki Y,Takashi Y,Hiroshi H,et al. Preparation of optical succinic acid derivatives. Ⅱ. Efficient and practical synthesis of KAD-1229[J]. Chem Pharm Bull,1998,46(2):337 -340.
5Kiyoshi I,Kazuyasu M,Makoto M,et al. Absence of exacerbation of myocardial stunning in anesthetized dogs treated with KAD-1229,a novel hypoglycemic agent[J]. Eur J Pharmacol,2001,431(3):331 -338.
6Yasuhiro S,Tohru G,Tadao S,et al. The effects of mitiglinide KAD-1229,a new anti-diabetic drug,on ATP-sensitive K+ channels and insulin secretion:comparison with the sulfonylureas and nateglinide[J]. Eur J Pharmacol,2001,431(1):119 -125.
7Toshiaki Y,Takashi Y,Hiroshi H,et al. Preparation of optically active succinic acid derivatives. Ⅰ. Optical resolution of 2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)-propinic acid[J]. Chem Pharm Bull,1997,45(9):1 518 -1 520.
8Kamijo T. Process for producing benzylsuccinic acid derivatives [P]. Eur Patent:0967204.1999 -12 -29.
